Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Improving Vaccine and Immunotherapy Design Using Biomaterials.

Literature DB >> 29249461

Improving Vaccine and Immunotherapy Design Using Biomaterials.

Michelle L Bookstaver¹, Shannon J Tsai¹, Jonathan S Bromberg², Christopher M Jewell³.

Abstract

Polymers, lipids, scaffolds, microneedles, and other biomaterials are rapidly emerging as technologies to improve the efficacy of vaccines against infectious disease and immunotherapies for cancer, autoimmunity, and transplantation. New studies are also providing insight into the interactions between these materials and the immune system. This insight can be exploited for more efficient design of vaccines and immunotherapies. Here, we describe recent advances made possible through the unique features of biomaterials, as well as the important questions for further study.

Entities: Chemical Disease Gene Species

Keywords: autoimmunity and transplantation; biomaterial and nanotechnology; cancer; infectious disease; nanoparticle and microparticle; vaccine and immunotherapy

Mesh：

Substances：

Year: 2017 PMID： 29249461 PMCID： PMC5914493 DOI： 10.1016/j.it.2017.10.002

Source DB: PubMed Journal: Trends Immunol ISSN： 1471-4906 Impact factor: 16.687

94 in total

1. Engineering antigens for in situ erythrocyte binding induces T-cell deletion.

Authors: Stephan Kontos; Iraklis C Kourtis; Karen Y Dane; Jeffrey A Hubbell
Journal: Proc Natl Acad Sci U S A Date: 2012-12-17 Impact factor: 11.205

Review 2. Current advances in the fabrication of microneedles for transdermal delivery.

Authors: Sunaina Indermun; Regina Luttge; Yahya E Choonara; Pradeep Kumar; Lisa C du Toit; Girish Modi; Viness Pillay
Journal: J Control Release Date: 2014-05-05 Impact factor: 9.776

3. Nanoparticle-Based Antivirulence Vaccine for the Management of Methicillin-Resistant Staphylococcus aureus Skin Infection.

Authors: Fei Wang; Ronnie H Fang; Brian T Luk; Che-Ming J Hu; Soracha Thamphiwatana; Diana Dehaini; Pavimol Angsantikul; Ashley V Kroll; Zhiqing Pang; Weiwei Gao; Weiyue Lu; Liangfang Zhang
Journal: Adv Funct Mater Date: 2016-02-05 Impact factor: 18.808

4. Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy.

Authors: Hengfeng Yuan; Wen Jiang; Christina A von Roemeling; Yaqing Qie; Xiujie Liu; Yuanxin Chen; Yifan Wang; Robert E Wharen; Kyuson Yun; Guojun Bu; Keith L Knutson; Betty Y S Kim
Journal: Nat Nanotechnol Date: 2017-05-01 Impact factor: 39.213

5. Design of Polyelectrolyte Multilayers to Promote Immunological Tolerance.

Authors: Lisa H Tostanoski; Yu-Chieh Chiu; James I Andorko; Ming Guo; Xiangbin Zeng; Peipei Zhang; Walter Royal; Christopher M Jewell
Journal: ACS Nano Date: 2016-09-07 Impact factor: 15.881

6. Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy.

Authors: Kamal D Srivastava; Alyssa Siefert; Tarek M Fahmy; Michael J Caplan; Xiu-Min Li; Hugh A Sampson
Journal: J Allergy Clin Immunol Date: 2016-04-26 Impact factor: 10.793

7. Injectable cryogel-based whole-cell cancer vaccines.

Authors: Sidi A Bencherif; R Warren Sands; Omar A Ali; Weiwei A Li; Sarah A Lewin; Thomas M Braschler; Ting-Yu Shih; Catia S Verbeke; Deen Bhatta; Glenn Dranoff; David J Mooney
Journal: Nat Commun Date: 2015-08-12 Impact factor: 14.919

8. A combination hydrogel microparticle-based vaccine prevents type 1 diabetes in non-obese diabetic mice.

Authors: Young Mee Yoon; Jamal S Lewis; Matthew R Carstens; Martha Campbell-Thompson; Clive H Wasserfall; Mark A Atkinson; Benjamin G Keselowsky
Journal: Sci Rep Date: 2015-08-17 Impact factor: 4.379

9. A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease.

Authors: Zoe Hunter; Derrick P McCarthy; Woon Teck Yap; Christopher T Harp; Daniel R Getts; Lonnie D Shea; Stephen D Miller
Journal: ACS Nano Date: 2014-02-27 Impact factor: 15.881

10. Targeted Delivery of Immunomodulators to Lymph Nodes.

Authors: Jamil Azzi; Qian Yin; Mayuko Uehara; Shunsuke Ohori; Li Tang; Kaimin Cai; Takaharu Ichimura; Martina McGrath; Omar Maarouf; Eirini Kefaloyianni; Scott Loughhead; Jarolim Petr; Qidi Sun; Mincheol Kwon; Stefan Tullius; Ulrich H von Andrian; Jianjun Cheng; Reza Abdi
Journal: Cell Rep Date: 2016-04-28 Impact factor: 9.423

49 in total

1. Engineering Biomaterials to Direct Innate Immunity.

Authors: R S Oakes; E Froimchuk; C M Jewell
Journal: Adv Ther (Weinh) Date: 2019-02-27

2. Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8⁺ Lung-Resident Memory T Cells.

Authors: Frances C Knight; Pavlo Gilchuk; Amrendra Kumar; Kyle W Becker; Sema Sevimli; Max E Jacobson; Naveenchandra Suryadevara; Lihong Wang-Bishop; Kelli L Boyd; James E Crowe; Sebastian Joyce; John T Wilson
Journal: ACS Nano Date: 2019-10-04 Impact factor: 15.881

Improving Vaccine and Immunotherapy Design Using Biomaterials.

1. Engineering antigens for in situ erythrocyte binding induces T-cell deletion.

Review 2. Current advances in the fabrication of microneedles for transdermal delivery.

3. Nanoparticle-Based Antivirulence Vaccine for the Management of Methicillin-Resistant Staphylococcus aureus Skin Infection.

4. Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy.

5. Design of Polyelectrolyte Multilayers to Promote Immunological Tolerance.

6. Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy.

7. Injectable cryogel-based whole-cell cancer vaccines.

8. A combination hydrogel microparticle-based vaccine prevents type 1 diabetes in non-obese diabetic mice.

9. A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease.

10. Targeted Delivery of Immunomodulators to Lymph Nodes.

1. Engineering Biomaterials to Direct Innate Immunity.

2. Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8⁺ Lung-Resident Memory T Cells.

Review 3. Directing toll-like receptor signaling in macrophages to enhance tumor immunotherapy.

4. Self-Assembly as a Molecular Strategy to Improve Immunotherapy.

Review 5. Induction of anti-cancer T cell immunity by in situ vaccination using systemically administered nanomedicines.

Review 6. Advances in immunotherapy delivery from implantable and injectable biomaterials.

7. Engineering release kinetics with polyelectrolyte multilayers to modulate TLR signaling and promote immune tolerance.

8. In Vivo Intradermal Delivery of Bacteria by Using Microneedle Arrays.

9. Drug-Mimicking Nanofibrous Peptide Hydrogel for Inhibition of Inducible Nitric Oxide Synthase.

Review 10. Engineering Immune Tolerance with Biomaterials.